242 related articles for article (PubMed ID: 6685700)
1. The significance of dapsone (DDS)-resistant Mycobacterium leprae in untreated patients.
Almeida JG; Chacko CJ; Christian M
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):374-7. PubMed ID: 6685700
[TBL] [Abstract][Full Text] [Related]
2. DDS-resistant infection among leprosy patients in the population of Gudiyatham Taluk, South India. Part 3. Prevalence, incidence, risk factors, and interpretation of mouse foot pad test results.
Almeida JG; Chacko CJ; Christian M; Taylor PM; Fritschi EP
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):366-73. PubMed ID: 6685699
[TBL] [Abstract][Full Text] [Related]
3. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
[TBL] [Abstract][Full Text] [Related]
4. Primary dapsone-resistant leprosy in San Francisco.
Gelber RH
Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
[TBL] [Abstract][Full Text] [Related]
5. Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates.
Gelber RH; Rea TH; Murray LP; Siu P; Tsang M; Byrd SR
Arch Dermatol; 1990 Dec; 126(12):1584-6. PubMed ID: 2256685
[TBL] [Abstract][Full Text] [Related]
6. Dapsone resistance in Mycobacterium leprae.
Gillis TP; Williams DL
Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
[TBL] [Abstract][Full Text] [Related]
7. Studies on sulphone resistant strains of M. leprae in field and institutionalized cases of leprosy.
Balakrishnan S; Seshadri PS; Neelan PN; Venkataramaniah HN; Harikrishnan S; Bhatia VN
Lepr India; 1983 Jan; 55(1):71-5. PubMed ID: 6348413
[TBL] [Abstract][Full Text] [Related]
8. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
9. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
10. Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time.
Murohashi T; Yoshida K
Acta Leprol; 1978; (73):13-28. PubMed ID: 108909
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity to dapsone, sulfamethoxypyridazine and ethionamide of mycobacterium leprae taken from patients treated by the drugs].
Pattyn SR; Rollier MT; Rollier R; Verdoolaeghe-Van Loo G
Int J Lepr Other Mycobact Dis; 1975; 43(4):356-63. PubMed ID: 776843
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
[TBL] [Abstract][Full Text] [Related]
13. Persister M. leprae after introductory rifampicin followed by dapsone therapy.
Sreevatsa ; Girdhar BK; Desikan KV
Lepr India; 1981 Jul; 53(3):350-3. PubMed ID: 7278139
[TBL] [Abstract][Full Text] [Related]
14. Comparison of radiometric macrophage assay and the mouse foot pad infection for the evaluation of Mycobacterium leprae sensitivity/resistance to dapsone.
Sathish M; Rees RJ; Seshadri PS; Nath I
Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):378-84. PubMed ID: 3900244
[TBL] [Abstract][Full Text] [Related]
15. Adenosine triphosphate content of Mycobacterium leprae from leprosy patients.
Dhople AM
Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):183-8. PubMed ID: 6373626
[TBL] [Abstract][Full Text] [Related]
16. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of drug resistance in Dharmapuri and A. Pallipatti areas of Tamil Nadu.
Sreevatsa ; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(2):376-82. PubMed ID: 3908580
[TBL] [Abstract][Full Text] [Related]
18. Secondary and primary dapsone resistant leprosy: an analysis of 199 patients from St. Thomas Hospital and leprosy project, Chettupattu, South India.
Aschhoff M; Raj PP; Lilly L; Srinivasan H
Indian J Lepr; 1988 Jan; 60(1):34-46. PubMed ID: 3060545
[TBL] [Abstract][Full Text] [Related]
19. Primary and secondary dapsone resistance of M. leprae in Martinique, Guadeloupe, New Caledonia, Tahiti, Senegal, and Paris between 1980 and 1985.
Guelpa-Lauras CC; Cartel JL; Constant-Desportes M; Millan J; Bobin P; Guidi C; Brucker G; Flageul B; Guillaume JC; Pichet C
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):672-9. PubMed ID: 3323369
[TBL] [Abstract][Full Text] [Related]
20. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
Walker LL; Van Landingham RM; Shinnick TM
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
